Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,250 across all filing types
Latest filing 2018-02-11 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the completion of a business registration change, specifically the increase in registered capital and the filing of related amendments to the company charter. It mentions the completion of share registration procedures and the issuance of a new business license. The document is short (1135 characters) and serves as a formal notice of these changes rather than a detailed financial report or presentation. There is no financial statement or detailed analysis included. This fits the category of Share Issue/Capital Change announcements, as it relates to an increase in registered capital and share issuance registration.
2018-02-11 Chinese
关于参与设立湖南三诺糖尿病公益基金会暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction where the company is donating funds to establish a charitable foundation. It includes details about the transaction, the parties involved, independent directors' opinions, and compliance with regulatory rules. The document is relatively short (2274 characters) and does not contain financial statements or detailed financial data. It is not a financial report but a regulatory announcement about a corporate action involving related parties and social responsibility. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-02-08 Chinese
第三届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of the company 三诺生物传感股份有限公司. It details the convening of the third Supervisory Board's twelfth meeting, the attendance, and the approval of a proposal regarding the use of idle funds to purchase low-risk financial products. The document is short (1122 characters) and does not contain financial statements or detailed financial data. It is an official announcement of a board meeting decision rather than a full management report or financial report. It does not fit categories like Annual Report, Interim Report, or Management Reports. It is not a regulatory filing or certification letter either. The best fitting category is Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies. Confidence is high given the clear meeting resolution content and the nature of the document.
2018-02-08 Chinese
独立董事关于公司第三届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the company's 18th board meeting of the third session, dated February 8, 2018. It includes assessments of the use of idle funds for low-risk financial products and participation in establishing a charitable foundation, including related party transactions. The document references compliance with regulatory guidelines and company bylaws, and it is signed by independent directors. The content is focused on board/management matters and independent director opinions rather than financial results, audit, or shareholder voting results. The document length is short (1480 characters) and does not contain financial statements or earnings data. Therefore, it is best classified as Board/Management Information (MANG).
2018-02-08 Chinese
第三届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 18th meeting of the third board of directors of the company. It details meeting attendance, voting results, and decisions on financial matters such as use of idle funds, establishment of a public welfare foundation, and increase in registered capital. The document is a board meeting resolution announcement rather than a full management report or financial statement. It does not contain comprehensive financial data or detailed management discussion but focuses on board decisions and approvals. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short (2023 characters), and it is not an announcement of a report publication but a substantive announcement of board resolutions.
2018-02-08 Chinese
关于使用闲置自有资金购买低风险理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the use of idle funds to purchase low-risk financial products. It details the investment purpose, amount, types of products, risk analysis, decision-making procedures, and opinions from independent directors and the supervisory board. The document is an announcement of a financing or capital management activity, specifically about using company funds for investment purposes. It is not a financial report, earnings release, or regulatory filing. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage. The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2018-02-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.